FeNO is associated with disease burden in the German Asthma Net severe asthma cohort

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of interest: Christina Bal has nothing to disclose.

Conflict of interest: Marco Idzko reports lectures fees from AstraZeneca, Bayer, Berlin-Chemie, Boehringer Ingelheim, Chiesi, CSL-Behring, GSK, Menarini, MSD, Novartis, Roche, Sanofi, Thermofischer and advisory board fees from Alk-Pharma, AstraZeneca, Berlin-Chemie, Boehringer Ingelheim, Chiesi, CSL-Behring, GSK, Novartis, and Sanofi, all outside the submitted work.

Conflict of interest: Sabina Škrgat reports fees from Boehringer Ingelheim, GSK, Novartis, AstraZeneca, and Chiesi, all outside the submitted work.

Conflict of interest: Andrea Koch reports personal fees from AstraZeneca, Novartis, Sanofi, and Boehringer Ingelheim, all outside the submitted work.

Conflict of interest: Katrin Milger reports personal fees from AstraZeneca, GSK, Novartis, and Sanofi, all outside the submitted work.

Conflict of interest: Christian Schulz received personal fees from Boehringer Ingelheim, Novartis, and AstraZeneca, all outside the submitted work.

Conflict of interest: Sonja Zehetmayer has nothing to disclose.

Conflict of interest: Eckard Hamelmann is funded by the German Ministry of Education and Research (BMBF) (CHAMP, Project Number: 01GL1742D) for characterisation of children and adolescents with severe asthma. He reports personal fees from ALK, Boehringer Ingelheim, GSK, Leti Pharma, Novartis, Nutricia, Sanofi, and Stallergenes all outside the submitted work.

Conflict of interest: Roland Buhl reports grants to Mainz University and personal fees from Boehringer Ingelheim, GSK, Novartis, and Roche, as well as personal fees from AstraZeneca, Chiesi, Cipla, Sanofi, and Teva, all outside the submitted work.

Conflict of interest: Stephanie Korn reports grants to Mainz University and personal fees from AstraZeneca, Boehringer Ingelheim, GSK, Novartis, Roche, and Sanofi, as well as personal fees from AstraZeneca, GSK, Novartis, Sanofi, and Teva, all outside the submitted work.